Vor Biopharma's market cap is currently $174.69M. The company's EPS TTM is $-1.649; its P/E ratio is ―; Vor Biopharma is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -3.49M	$ -8.96M	$ -4.45M	$ -1.39M	$ -91.00K
Operating Income	$ -126.04M	$ -93.42M	$ -69.02M	$ -43.37M	$ -10.42M
EBITDA	$ -114.37M	$ -90.89M	$ -67.58M	$ -41.95M	$ -10.17M
Net Income	$ -117.86M	$ -90.77M	$ -68.78M	$ -43.34M	$ -11.45M
Balance Sheet
Cash & Short-Term Investments	$ 137.18M	$ 230.25M	$ 207.47M	$ 48.54M	$ 6.47M
Total Assets	$ 198.13M	$ 299.37M	$ 242.59M	$ 75.91M	$ 9.83M
Total Debt	$ 35.66M	$ 38.91M	$ 18.01M	$ 18.29M	$ 0.00
Net Debt	$ 4.30M	$ -18.79M	$ -101.79M	$ -30.25M	$ -6.47M
Total Liabilities	$ 47.40M	$ 48.76M	$ 26.33M	$ 27.64M	$ 2.19M
Stockholders' Equity	$ 150.72M	$ 250.61M	$ 216.26M	$ 48.27M	$ 7.64M
Cash Flow
Free Cash Flow	$ -101.36M	$ -93.61M	$ -73.04M	$ -40.45M	$ -10.60M
Operating Cash Flow	$ -100.29M	$ -85.14M	$ -69.14M	$ -36.29M	$ -9.86M
Investing Cash Flow	$ 71.01M	$ -94.09M	$ -91.65M	$ -4.16M	$ -748.00K
Financing Cash Flow	$ 2.94M	$ 117.14M	$ 232.91M	$ 82.53M	$ 17.70M

Currency in USD

Vor Biopharma Earnings and Revenue History

Income Statement >

Vor Biopharma Debt to Assets

Balance Sheet >

Vor Biopharma Cash Flow

Cash Flow >

Vor Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing